Pentamidine

Revision as of 01:52, 20 March 2026 by Danbot (talk | contribs) (Replace manual dosing with dynamic SMW tables (Adult + Pediatric))

Administration

  • Type: Antifungal Agent; Antiprotozoal
  • Routes of Administration: IM, IV
  • Common Trade Names: Pentam

Adult Dosing

Indications by Disease

DiseaseDoseContext
Pneumocystis jirovecii pneumonia4mg/kg IV daily over 60 minSevere disease

Pediatric Dosing

Indications by Disease

DiseaseDoseContext
Pneumocystis jirovecii pneumonia4mg/kg IV daily x 21 daysPediatric Severe, TMP/SMX intolerant

Special Populations

  • Pregnancy Risk Factor C

Renal Dosing

  • CrCl <10: give q24-36h
  • HD: give 750mg supplement
  • PD: no supplement

Hepatic Dosing

  • Caution advised with hepatic impairment

Contraindications

  • Allergy to class/drug
  • congenital long QT syndrome
  • electrolyte abnormalities, uncorrected
  • caution if QT prolongation

Adverse Reactions

Serious

  • extravasation/tissue damage
  • hypoglycemia
  • hyperglycemia
  • diabetes mellitus
  • pancreatitis
  • nephrotoxicity

Common

  • renal dysfunction
  • BUN, creatinine elevated
  • injection site necrosis
  • leukopenia
  • transaminitis

Pharmacology

  • Half-life: 2-4 weeks
  • Metabolism: Liver
  • Excretion: Urine

Mechanism of Action

protozocidal - interferes with nuclear metabolism

Comments

See Also

References

<Epocrates, UpToDate>